Contact
Please use this form to send email to PR contact of this press release:
GSK receives further data from phase lll studies of albiglutide in type 2 diabetes
TO:
Please use this form to send email to PR contact of this press release:
GSK receives further data from phase lll studies of albiglutide in type 2 diabetes
TO: